Testing effectiveness (Phase 2)Study completedNCT00002635What this trial is testingAminocamptothecin in Treating Patients With T-cell LymphomaWho this might be right forLymphoma Yale University 12
Early research (Phase 1)Study completedNCT00019019What this trial is testingCarboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory LymphomasWho this might be right forBrain and Central Nervous System TumorsBreast CancerKidney Cancer+6 more National Institutes of Health Clinical Center (CC) 70
Testing effectiveness (Phase 2)Study completedNCT00255801What this trial is testingLiposomal Doxorubicin Followed By Bexarotene in Treating Patients With Cutaneous T-Cell LymphomaWho this might be right forLymphoma Memorial Sloan Kettering Cancer Center 37
Early research (Phase 1)Study completedNCT00006009What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Advanced or Recurrent LymphomaWho this might be right forLymphomaSmall Intestine Cancer Stanford University
Early research (Phase 1)Study completedNCT00659568What this trial is testingMetformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or LymphomaWho this might be right forBreast CancerEndometrial CancerKidney Cancer+3 more London Health Sciences Centre 28
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544115What this trial is testingDonor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other DisordersWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+5 more City of Hope Medical Center 260
Early research (Phase 1)Study completedNCT00348985What this trial is testingPXD101 and Bortezomib in Treating Patients With Advanced Solid Tumors or LymphomasWho this might be right forAdult Grade III Lymphomatoid GranulomatosisAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+58 more National Cancer Institute (NCI) 55
Early research (Phase 1)Active Not RecruitingNCT02520791What this trial is testingAnti-ICOS Monoclonal Antibody MEDI-570 in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma Follicular Variant or Angioimmunoblastic T-cell LymphomaWho this might be right forAdvanced Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-TypeRecurrent Grade 1 Follicular Lymphoma+16 more National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00088868What this trial is testing17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institutes of Health Clinical Center (CC) 40
Large-scale testing (Phase 3)Ended earlyNCT01098656What this trial is testingLenalidomide Maintenance Post-debulking in Advanced CTCLWho this might be right forLymphoma European Organisation for Research and Treatment of Cancer - EORTC 21
Early research (Phase 1)WithdrawnNCT00004114What this trial is testingChemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center
Early research (Phase 1)Ended earlyNCT00060112What this trial is testingOblimersen and Gemcitabine in Treating Patients With Advanced Solid Tumor or LymphomaWho this might be right forExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid TissueNodal Marginal Zone B-cell LymphomaRecurrent Adult Burkitt Lymphoma+31 more National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00301951What this trial is testingLow-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of California, San Francisco 7
Early research (Phase 1)Study completedNCT00005634What this trial is testingSuberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous TherapyWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Study completedNCT00002687What this trial is testingInterleukin-2 in Treating Patients With Mycosis FungoidesWho this might be right forLymphoma University of Washington 30
Early research (Phase 1)Study completedNCT01164709What this trial is testingNelfinavir Mesylate and Bortezomib in Treating Patients With Relapsed or Progressive Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMature T-cell and Nk-cell Neoplasms+1 more Swiss Cancer Institute 18
Early research (Phase 1)Study completedNCT00004189What this trial is testingRebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced CancerWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00020579What this trial is testingMS-275 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forCancer National Institutes of Health Clinical Center (CC) 75
Early research (Phase 1)Study completedNCT00004002What this trial is testingPS-341 in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific NYU Langone Health
Early research (Phase 1)Study completedNCT00646139What this trial is testingKX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to TreatmentWho this might be right forLymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more Roswell Park Cancer Institute 7